Unique ID issued by UMIN | C000000433 |
---|---|
Receipt number | R000000525 |
Scientific Title | Randamized clinical trial of pars plana vitrectomy for macular edema from branch retinal vein occlusion |
Date of disclosure of the study information | 2006/06/30 |
Last modified on | 2015/05/11 08:36:34 |
Randamized clinical trial of pars plana vitrectomy for macular edema from branch retinal vein occlusion
Randamized clinical trial of pars plana vitrectomy for macular edema from branch retinal vein occlusion
Randamized clinical trial of pars plana vitrectomy for macular edema from branch retinal vein occlusion
Randamized clinical trial of pars plana vitrectomy for macular edema from branch retinal vein occlusion
Japan |
Patients with macular edema from branch retinal vein occlusion
Ophthalmology |
Others
NO
Randamized clinical trial of pars plana vitrectomy and grid laser photocoagulation for patients with macular edema from branch retinal vein occlusion. Improvement of the visual outcome and foveal retinal thickness for the patients.
Efficacy
Confirmatory
Explanatory
Not applicable
12 months distant visual acuity
12 months foveal retinal thickness
Course of distant visual acuity over treatment period
Course of foveal retinal thickness over treatment period
Ischemic maculopathy at 12 months
Interventional
Parallel
Randomized
Individual
Open -no one is blinded
Active
NO
NO
Institution is not considered as adjustment factor.
YES
Central registration
2
Treatment
Maneuver |
Group1: grid laser photocoagulation
Group2: pars plana vitrectomy
20 | years-old | <= |
80 | years-old | >= |
Male and Female
Participants must have center-involved macular edema secondary to branch retinal vein occlusion documented for at least 2 months and not longer 18 months
Visual acuity greater than or equal to 0.1 (logMAR1.0) and less than or equal to 0.5 (logMAR0.3)
Foveal retinal thickness greater than or equal to 250 microns of the optical coherence tomography (mean of 2 measurements).
Ischemic maculopathy and macular degeneration
Presence of hemorrhage directly in the fovea
Additional ocular disease reducing the visual acuity
Sitting systolic blood pressure greater than 180 mmHg or diastolic blood pressure greater than 110 mmHg at the screening visit
History of systemic corticosteroids within 4 months prior to randomization
History of laser photocoaguration for macular edema
History of major ocular surgery within 6 months prior to randomization
History of peribulbar or retrobulbar or intravitreal corticosteroid use
History of pars plana vitrectomy
Aphakia
Pregnancy
History of allergy to fluorescein
uncontrollable systemic disease
participation in another trial
160
1st name | |
Middle name | |
Last name | Taiji Sakamoto |
Kagoshima University Graduate School of Medical and Dental Sciences
Ophthalmology
8-35-1 Sakuragaoka, Kagoshima JAPAN
099-275-5402
tsakamot@m3.kufm.kagoshima-u.ac.jp
1st name | |
Middle name | |
Last name | Taiji Sakamoto |
Kagoshima University Graduate School of Medical and Dental Sciences
Ophthalmology
8-35-1 Sakuragaoka, Kagoshima JAPAN
099-275-5402
tsakamot@m3.kufm.kagoshima-u.ac.jp
Kagoshima University Graduate School of Medical and Dental Sciences
None
Self funding
NO
2006 | Year | 06 | Month | 30 | Day |
Unpublished
Terminated
2006 | Year | 03 | Month | 22 | Day |
2006 | Year | 04 | Month | 01 | Day |
2012 | Year | 03 | Month | 01 | Day |
2006 | Year | 06 | Month | 20 | Day |
2015 | Year | 05 | Month | 11 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000000525